Pascal Levensohn
Senior Managing Director @ Dolby Family Ventures
San Francisco, United States
Pascal Levensohn is a Series A investor at Dolby Family Ventures in San Francisco focused on Software and 3D Technology. Pascal is the founder and Managing Partner of Levensohn Venture Partners (LVP) and the CEO of Generation Strategic Advisors LLC (GSA); he has held both positions since 1996. Pascal joined Dolby Family Ventures, L.P. as a Managing Director in 2014 after advising the Dolby family on its direct technology investment portfolio since 2012. Pascal hastransitioned his new technology venture capital investing activities to the Dolby family organization.Pascal was elected to the board of the National Venture Capital Association (NVCA) from April 2007-April 2011, during which he chaired the NVCA’s education committee for three years; he is a faculty member of the Kauffman Fellows Program Center for Venture Education (2006-present) where he teaches best practices for VC-backed company board members.Pascal has served as board chairman, audit committee chairman, compensation committee chairman, and board secretary for venture-backed companies since 1996 and as a public company director since 1993. In addition to serving as chairman on the ShotSpotter board, he is a co-founder and director of LittleCast, Inc. and currently on the boards of Akros Silicon, Tandent Vision Science, and Highview Healthcare.Pascal holds an AB in Government, cum laude, from Harvard University. He is a life member of the Council on Foreign Relations, a former co-chairman of the Socrates Society Forum of the Aspen Institute (2007-2009), and a former Chairman of the San Francisco Jewish Community Federation’s Business Leadership Council (2007-2008).
- Total investments:
- 17
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Pascal Levensohn invests in
Stages Pascal Levensohn invests in
Countries Pascal Levensohn invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (12%)
- 3D Technology 2 (12%)
- Art 1 (6%)
- CAD 1 (6%)
- SMS 1 (6%)
Stage
- Series A 4 (24%)
- Seed 3 (18%)
- Series B 1 (6%)
- Series C 1 (6%)
- Series D 1 (6%)
Country
- United States 7 (41%)
- Switzerland 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Therini Bio is dedicated to the research and development of novel therapeutics for the treatment of neurological diseases. The company's approach is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation. | $39M / Series A / May 14, 2025 | ||
| Therini Bio is dedicated to the research and development of novel therapeutics for the treatment of neurological diseases. The company's approach is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation. | $36M / Series A / Apr 27, 2023 | ||
| Therini Bio is dedicated to the research and development of novel therapeutics for the treatment of neurological diseases. The company's approach is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation. | $17M / Seed / May 10, 2021 | ||
| GenomSys is a Swiss company composed by engineers with extensive experience in research, development and project management in high-end domains and industrial segments such as digital signal processing, telecommunications, information security and avionics. Their experience spans from embedded software and firmware for low-power devices to hardreal-time programming in safety-critical environments up to the design and integration of desktop and server applications in the digital multimedia and telecommunications market. All the engineers are extensively accustomed to the ISO process of standardization, with experience in development and normative editing of audiovisual coding, systems and conformance testing standards. | $9.4M / Series A / Sep 16, 2019 | ||
| Therini Bio is dedicated to the research and development of novel therapeutics for the treatment of neurological diseases. The company's approach is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation. | $9.4M / Seed / Jul 08, 2019 | ||
| Lightform's products transform spaces & experiences using projection mapping, adding magical effects & ambient interfaces to any 3D object. | $8.7M / Series A / Jun 04, 2019 | ||
| Lightform's products transform spaces & experiences using projection mapping, adding magical effects & ambient interfaces to any 3D object. | $5M / Seed / Nov 21, 2017 | ||
| Modsy combines advanced 3D graphics, computer vision, and creative curation to provide its customers with home design guidance and plans. It allows its customers to see inspirational designs and decor within the context of their own home and shows ideas for their space before making any changes. Modsy helps new homeowners, remodelers, and renterscreate an ideal, personalized design.It was founded in 2015 and is headquartered in San Francisco, California. | $8M / Series A / Feb 02, 2016 | ||
| ShotSpotter they helps local, state, and federal law enforcement respond to, investigate, and deter crime through gunshot detection and alerting systems; investigative tools that immediately generate leads and streamline case management to accelerate crime solving and improve clearance rates; and patrol management software. | $9.7M / Venture - Series Unknown / Sep 08, 2015 | ||
| Mixed Dimensions is an integral reality company, creating new systems and technologies for the virtual and physical worlds to relate to one another by bridging the digital and physical worlds through an innovative software platform.Its manufacturing innovative technology enables on demand, no inventory, processing of one of a kind objectsrealized through leading edge 3D printing, robotics, and artists delivering products that bring the imagination from the virtual world to life for use in our physical world. | $4.3M / Convertible Note / Feb 15, 2015 | ||
| See all 17 investments → | |||
Co-Investors
About Dolby Family Ventures
Dolby Family Ventures is an early stage venture firm focused on building great technology companies. They partner with best-in-class innovators and strong investment syndicate partners at the seed stage of a company’s development. Unlike many seed investors, They intend to continue to invest across future rounds in our successful portfolio companies.
Dolby Family Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Krowne
Managing Director
|
|||
David Dolby
CEO
|
|||
|
Kavan Canekeratne
Associate; Associate
|
|||
|
Pascal Levensohn
Senior Managing Director
|
|||
Reetika Bhardwaj
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Pascal Levensohn invest in?
Pascal Levensohn invests primarily in Software, 3D Technology and Art startups, most often at Series A and Seed stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Pascal Levensohn?
Public channels for Pascal Levensohn include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Pascal Levensohn last invest?
The most recent investment recorded for Pascal Levensohn closed in May 2025. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
